Available
Revaxis Logo

REVAXIS® OVERVIEW

REVAXIS is a 3-in-1 booster vaccine that helps protect against three separate diseases: diphtheria, tetanus and poliomyelitis (polio).

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

REVAXIS Prescribing information

View the REVAXIS SmPC

Why help protect your patients with REVAXIS?

REVAXIS helps boost protection against diphtheria, tetanus and polio in a single injection. Revaxis is given as part of the national immunisation programme to teenagers at around 14 years of age (school year 9), providing the fifth and final routine vaccine against tetanus, diphtheria and polio.

 

Presentation

Schedule

Further doses

Age range


Logo Revaxis

Diphtheria, tetanus and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

0.5 ml prefilled syringe Available in 1 syringe packs

1 dose

Revaxis® may be used as a booster following primary immunisation with inactivated or oral poliomyelitis vaccines Revaxis® is indicated as a booster following primary vaccination. Revaxis® is not intended for primary immunisation

6 years +

 

REVAXIS SmPC

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

REVAXIS Prescribing information

View the REVAXIS SmPC

Materials Ordering Online – Giving You Access to A Range Of Support Materials

Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.

• Simply visit https://sanofi.medisa.com

• Select the user group which best describes your role in your organisation

• Narrow your search by selecting the appropriate disease area

• Select which materials you would like to receive and how many

• Log-in or register to create an account

• Confirm your order

VISIT MEDISA

 

Date of preparation: November 2018 | SAGB.MIS.18.08.1323u